Covalon Technologies Ltd (COV)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Covalon Technologies Ltd (COV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013168
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Covalon Technologies Ltd (Covalon) is a researcher, developer and commercialization of medical devices and healthcare technologies. The company offers advanced wound solutions, infection prevention products and perioperative care products. Covalon offers wound care products such as collagen matrix dressing, collagen matrix dressing with silver, wound contact layer, non-adherent foam dressing and superabsorbent dressing, among others. Its infection prevention products and perioperative care product includes self-adherent silicone dressing with absorbent pad, antimicrobial clear silicone adhesive dressing with chlorhexidine and silver and silicone foley catheter, among others. The company also develops and commercializes proprietary technologies in the areas of advanced wound care, cardiology, urology, vascular access, orthopaedics and surgery, among others. Covalon is headquartered in Mississauga, Ontario, Canada.

Covalon Technologies Ltd (COV) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Covalon Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Covalon Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Covalon Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Covalon Technologies Ltd, Medical Devices Deals, 2011 to YTD 2017 8
Covalon Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Covalon Technologies Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Covalon Technologies Enters Into Distribution Agreement With Molnlycke Health Care For SurgiClear And IV Clear 10
Licensing Agreements 12
Covalon Enters into Licensing Agreement with University of Michigan 12
Equity Offering 13
Covalon Tech Raises USD1.7 Million in Private Placement of Units 13
Covalon Tech Raise USD0.6 Million in Private Placement of Shares upon Exercise of Warrants 14
Covalon Tech Raises USD0.8 Million in Private Placement of Shares upon Exercise of Warrants 15
Covalon Technologies Completes Private Placement Of Shares For US$2.5 Million 16
Debt Offering 17
Covalon Technologies Completes Private Placement Of Units For US$0.7 Million 17
Covalon Technologies Ltd – Key Competitors 19
Covalon Technologies Ltd – Key Employees 20
Covalon Technologies Ltd – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Strategy And Business Planning 22
Jun 01, 2016: Covalon Announces Further Expansion in the Middle East 22
Financial Announcements 23
Aug 21, 2017: Covalon Releases Third Quarter Financial Results 23
May 29, 2017: Covalon Releases Second Quarter Financial Results 24
Jan 30, 2017: Covalon Posts Record First Quarter Financial Results 25
Aug 19, 2016: Covalon Announces Third Quarter Financial Results 26
May 30, 2016: Covalon Announces Second Quarter Financial Results 27
Feb 29, 2016: Covalon Announces Strong First Quarter Financial Results 28
Jan 27, 2016: Covalon Announces Annual Financial Results 29
Corporate Communications 30
Nov 14, 2017: US Major General Gale S. Pollock (Ret.) Joins Covalon’s Board of Directors 30
Other Significant Developments 31
Jan 03, 2017: Covalon CEO Provides Update on Anticipated Fiscal 2017 Financial Growth 31
Jun 07, 2016: Covalon Announces Participation in Ontario Government’s Medical Trade Mission to Mexico 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Covalon Technologies Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Covalon Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Covalon Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Covalon Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Covalon Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Covalon Technologies Ltd, Medical Devices Deals, 2011 to YTD 2017 8
Covalon Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Covalon Technologies Enters Into Distribution Agreement With Molnlycke Health Care For SurgiClear And IV Clear 10
Covalon Enters into Licensing Agreement with University of Michigan 12
Covalon Tech Raises USD1.7 Million in Private Placement of Units 13
Covalon Tech Raise USD0.6 Million in Private Placement of Shares upon Exercise of Warrants 14
Covalon Tech Raises USD0.8 Million in Private Placement of Shares upon Exercise of Warrants 15
Covalon Technologies Completes Private Placement Of Shares For US$2.5 Million 16
Covalon Technologies Completes Private Placement Of Units For US$0.7 Million 17
Covalon Technologies Ltd, Key Competitors 19
Covalon Technologies Ltd, Key Employees 20
Covalon Technologies Ltd, Other Locations 21

★海外企業調査レポート[Covalon Technologies Ltd (COV)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ifa systems AG (IS8):企業の財務・戦略的SWOT分析
    ifa systems AG (IS8) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ZAPPALLAS, Inc. (3770):企業の財務・戦略的SWOT分析
    ZAPPALLAS, Inc. (3770) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Second Genome Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Second Genome Inc (Second Genome), formerly PhyloTech Inc, is a clinical stage pharmaceutical company that provides microbial research and drug discovery services. The company’s pipeline products include SGM-1019, a small molecule inhibitor targeting tissue injury and inflammation; and SG-2- …
  • Greencore Group Plc:企業のM&A・事業提携・投資動向
    Greencore Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Greencore Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • InFlectis BioScience-製薬・医療分野:企業M&A・提携分析
    Summary InFlectis BioScience (InFlectis) is a drug discovery company that discovers and develops small molecule drugs that target the unfolded protein response (UPR) to treat misfolding protein disorders such as age-related and neurodegenerative diseases. The company’s product lead candidate IFB-088 …
  • MDNA Life Sciences Inc-医療機器分野:企業M&A・提携分析
    Summary MDNA Life Sciences Inc (MDNA) is a molecular diagnostics company that develops molecular tests based on the mitochondrial genome. The company’s prostate core mitomic test (PCMT) based on the science of mitochondrial DNA (mtDNA) is a tissue-based prostate cancer diagnostics for prostate and o …
  • Marathon Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Marathon Pharmaceuticals LLC (Marathon Pharmaceuticals) focuses on the development, manufacturing and commercialization of treatments for rare neurological and movement disorders. It develops products in various therapeutic areas which include duchenne muscular dystrophy, pediatric juvenile …
  • Absorption Systems LP-製薬・医療分野:企業M&A・提携分析
    Summary Absorption Systems LP (Absorption Systems) is a pre-clinical contract research organization that develops and implements research tools. The organization carries out preclinical testing of drugs, biologics, and medical devices. It develops and implements research tools to predict human outco …
  • Maruho Co Ltd:企業の戦略的SWOT分析
    Maruho Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Mediacom Communications Corporation:企業の戦略的SWOT分析
    Mediacom Communications Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Groupe Bruxelles Lambert SA (GBLB):企業の財務・戦略的SWOT分析
    Groupe Bruxelles Lambert SA (GBLB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Swissgrid AG:電力:M&Aディール及び事業提携情報
    Summary Swissgrid AG (Swissgrid) is a national grid company that operates, maintains, modernizes and expands the electricity transmission system in Switzerland. It conducts the import and export of electricity to maintain the utilization levels. The company also provides additional services, such as …
  • Exelon Corporation (EXC)-エネルギー分野:企業M&A・提携分析
    Summary Exelon Corporation (Exelon) is a utility services holding company operating across the energy value chain comprising power generation, distribution, transmission and energy sales. It generates electricity from diverse sources, including nuclear, fossil fuels and renewable energy. Exelon deli …
  • Lloyds Banking Group Plc:企業の戦略・SWOT・財務情報
    Lloyds Banking Group Plc - Strategy, SWOT and Corporate Finance Report Summary Lloyds Banking Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • JAFCO Co., Ltd.:企業のM&A・事業提携・投資動向
    JAFCO Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's JAFCO Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • SURFnet bv:企業の戦略的SWOT分析
    SURFnet bv - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Stolt-Nielsen Ltd (SNI):企業の財務・戦略的SWOT分析
    Stolt-Nielsen Ltd (SNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Chiyoda Corp (6366):企業の財務・戦略的SWOT分析
    Chiyoda Corp (6366) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Imperial College London-製薬・医療分野:企業M&A・提携分析
    Summary Imperial College London (Imperial) is a research university that offers educational services. The university provides undergraduate and postgraduate courses. It offers courses in the field of science and technology, agriculture, business, the humanities, and medicine. It conducts clinical tr …
  • San Raffaele Hospital-製薬・医療分野:企業M&A・提携分析
    Summary San Raffaele hospital (San Raffaele), a subsidiary of Vita-Salute San Raffaele University is a clinical scientific university institution that offers education and healthcare services. The institute provides services through the segments clinic, scientific research, patient services, and hos …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆